You Are Invited to Attend A CNE Accredited Dinner Program!

You Are Invited to Attend A CNE Accredited Dinner Program!
***PLEASE SEE INDIVIDUAL TAB ABOVE FOR SPECIFIC MEETING LOCATION DATES AND TIMES***     
       
Program Summary:

This live CNE-accredited activity will provide nurses who care for patients with multiple myeloma with information regarding the pathology of multiple myeloma as well as the state-of-the art changes in treatment paradigms that provide practical and reliable information that promote the efficient application of current standards of care into clinical practice and ultimately improve patient outcomes. 

This activity will provide 2.0 Contact Hours

There is no fee for participating in this activity

This activity is intended for healthcare providers who care for patients with multiple myeloma

                ***Please email any questions about this program to [email protected]***

Learning Objectives:
After completing this activity, participants should be able to:

1.  Analyze disease-specific and patient-specific considerations for diagnosis, risk-assessment, and treatment implications for patients with Multiple Myeloma (MM).

2.  Identify optimal management strategies for patients based on disease status and current and emerging practice guidelines and recommendations.

3.  Develop effective strategies to minimize and manage disease- and therapy-associated adverse events in MM patients.

4. Formulate strategies for improving treatment adherence and persistence for individual patients with MM.
Accreditation Information: 

Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity will fulfill Category 2 contact hours requirements for pharmacology for ANCC-certified advanced practice nurses and ONCC/ILNA recertification points in the following categories: Scientific Basis for Practice; Treatment Modalities.
Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Millennium Pharmaceuticals.
Don't have an account yet? Register Now!

Sign in to your account